Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B
Clinical trial NCT03307980 · COMPLETED
Trial details
- NCT number
- NCT03307980
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2026-07-23
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.